While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert…
ELMWOOD PARK, N.J., August 1, 2025 /PRNewswire/ -- ELLKAY, a leading strategic data management partner in healthcare, is proud to announce…
Company doubles down on its commitment to transform personal health journey of every American at invitation-only Health Tech Ecosystem event…